Received: 23 December 2020
Accepted: 27 July 2021
First Online: 9 August 2021
: Institutional Review Board (IRB) approval was obtained for the parent TRACE-CORE study from the Committee for the Protection of Human Subjects in Research at the University of Massachusetts Medical School (UMMS) and the other study sites, including Saint Vincent Hospital/Fallon Clinic/Fallon Community Health Plan Research Review Committee IRB, Medical Center of Central Georgia IRB, Mercer University IRB and Office of Research Compliance, Kaiser Permanente Georgia IRB, Northside Hospital IRB. All participants provided written informed consent. Additional IRB approval was obtained from the Committee for the Protection of Human Subjects in Research at UMMS to access EHR notes for this study. All methods were performed in accordance with the IRB guidelines and regulations.
: Not applicable.
: Dr. McManus reports grants and personal fees from Bristol Myers Squibb, grants and personal fees from Pfizer, grants from Boehringer Ingelheim, non-financial support from Apple, personal fees and non-financial support from Samsung, grants and personal fees from Flexcon, personal fees from Boston Biomedical, personal fees from Rose Consulting, grants and personal fees from Heart Rhythm Society, personal fees and non-financial support from Fitbit, outside the submitted work. The other authors report no competing interests.